Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1997
An experimental model to study the cytotoxic effects induced by beta-amyloid, histamine, LPS and serum from Alzheimer patients on cultured rat endothelial cellsE Maneiro, V R Lombardi, R Lagares, et al.Neuroscience Letters|February 23, 1999
19/20 kDa low molecular weight serum protein pattern: a novel potential biochemical prognostic marker for different types of dementiaV R Lombardi, R CacabelosJournal of Neuroscience Research|November 20, 1998
Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypesV R Lombardi, M García, R CacabelosJournal of Neuroimmunology|July 17, 1999
Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individualsV R Lombardi, M García, L Rey, et al.Methods and Findings in Experimental and Clinical Pharmacology|July 27, 1999
Effects of Cerebrolysin on in vitro primary microglial and astrocyte rat cell culturesV R Lombardi, M Windisch, M García, et al.Acta Neurologica Scandinavica. Supplementum|March 23, 2001
A pharmacogenomic approach to Alzheimer's diseaseR Cacabelos, A Alvarez, L Fenández-Novoa, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 22, 2001
Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's diseaseA C Allison, R Cacabelos, V R Lombardi, et al.Journal of Neural Transmission. Supplementum|August 29, 2000
Cerebrolysin reduces microglial activation in vivo and in vitro: a potential mechanism of neuroprotectionX A Alvarez, V R Lombardi, L Fernández-Novoa, et al.Journal of Nutritional Science and Vitaminology|January 1, 1992
Brain histamine: psychoneuroimmune regulator in physiological and pathological conditionsR CacabelosPageof 10